Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15389205.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have treated extensive lentigo maligna in two elderly patients with Imiquimod 5% (Aldara). It was applied 3 times weekly, for 3 to 5 months. Clinical and histological remission was observed over 13 months of follow-up care. Tolerance was good. We suggest that topical imiquimod could be an interesting therapeutic alternative.
Medical subject headings
- Aminoquinolines
- Antineoplastic Agents
- Hutchinson's Melanotic Freckle
- Skin Neoplasms